Predict your next investment

Clover Therapeutics company logo
HEALTHCARE | Drug Delivery
clovertherapeutics.eu

See what CB Insights has to offer

Stage

Biz Plan Competition | Alive

About Clover Therapeutics

Clover Therapeutics is developing a technology platform based on drug delivery and biomimicry, whose first application will be in the urological oncology field, specifically against Bladder Cancer.

Clover Therapeutics Headquarter Location

Bari, 70054,

Italy

Latest Clover Therapeutics News

Clover Health Launches Clover Therapeutics

Jul 11, 2019

Clover Health has launched  Clover Therapeutics , a research subsidiary focused on developing medicines for older adults. Clover Therapeutics also announced it entered into a research collaboration and license agreement with Genentech, a member of the Roche Group, to better understand the genomic factors that increase an individual’s risk for developing ocular diseases. “Clover Therapeutics was created to address the significant unmet needs in chronic progressive diseases in the Medicare population. By partnering with our members to study the clinical and genetic drivers of ocular diseases, combined with Genentech’s pioneering history of drug discovery and development in this area, we hope to improve the quality of life for seniors living with these conditions.” – Cheng Zhang, Head of Clover Therapeutics. “Partnering with Clover Therapeutics will help further our understanding of ocular disease through our shared vision of using clinical and genomic data to develop personalized medicines.” – James Sabry, M.D., Ph.D., Global Head of Pharma Partnering, Roche. As a Medicare Advantage insurer, Clover Health is committed to improving health outcomes across a wide range of medical conditions its members may experience. Bringing innovative, high-quality medical solutions to all patients under its care makes the company unique among Medicare Advantage plans. The work of Clover Therapeutics is an extension of this mission, as it strives to accelerate the development of therapies for diseases that commonly afflict older people. Additionally, Clover Health’s diverse member population provides the opportunity to serve patients of multiple ethnicities and provide further evidence of the genes linked to aging-related diseases. This knowledge can help inform the development of targeted therapies, as well as identify patients most likely to benefit from treatment. Share this

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Clover Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Clover Therapeutics is included in 1 Expert Collection, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.